EATRIS

NeurATRIS is the French node of EATRIS, and is the only node exclusively dedicated to neuroscience.

Visit the EATRIS France page here.

EATRIS is the European infrastructure for translational medicine. The organisation brings together resources and services for research communities to translate scientific discoveries into benefits for patients in a variety of diseases, including neurological, cardiological and oncological diseases.

EATRIS provides access to a vast array of pre-clinical and clinical expertise and facilities that are available within 127+ top-tier academic centres across Europe. The focus of the infrastructure is on improving and optimising preclinical and early clinical development of drugs, vaccines and diagnostics, and overcoming barriers to health innovation.

EATRIS offers a broad range of research services for both academia and industry across various research fields. In addition, the organisation works with public funding agencies, charities and policy makers with tailored actions to help improve the translational research and innovation ecosystem.

NeurATRIS is part of the EATRIS-Plus project.

EATRIS-Plus is a Horizon 2020 project that aims to build further capabilities and deliver innovative scientific tools to support the long-term sustainability strategy of EATRIS as one of Europe’s key research infrastructures for Personalised Medicine.

The main goals of EATRIS-Plus are to:

• Consolidate EATRIS capacities in the field of Personalised Medicine (particularly omics technologies) to better serve academia and industry and augment the number of EATRIS Innovation Hubs with large pharma;
• Drive patient empowerment through active involvement in the infrastructure’s operations;
• Expand strategic partnerships with research infrastructures and other relevant stakeholders, and
• Further strengthen the long-term sustainability of the EATRIS financial model.

Find out more about the EATRIS-Plus project here EATRIS-Plus.